Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Privatdozent/in, Innere Klinik (Tumorforschung)
Aktuelle Veranstaltungen
-
2023 SS
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world settingIn: Journal of Cancer Research and Clinical Oncology (2023) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
Palliative care outpatients in a German comprehensive cancer center : identifying indicators for early and late referralIn: BMC Palliative Care Jg. 21 (2022) Nr. 1,ISSN: 1472-684XOnline Volltext: dx.doi.org/ (Open Access)
-
Prediction of Short and Long Survival after Surgery for Breast Cancer Brain MetastasesIn: Cancers Jg. 14 (2022) Nr. 6,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Radiographic markers of breast cancer brain metastases : relation to clinical characteristics and postoperative outcomeIn: Acta Neurochirurgica Jg. 164 (2022) S. 439 - 449ISSN: 0942-0940; 0001-6268Online Volltext: dx.doi.org/ (Open Access)
-
The OUTREACH study : oncologists of German university hospitals in rotation on a palliative care unit—evaluation of attitude and competence in palliative care and hospiceIn: Journal of Cancer Research and Clinical Oncology (2022) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgeryIn: Journal of Neuro-Oncology Jg. 159 (2022) Nr. 1, S. 53 - 63ISSN: 1573-7373; 0167-594XOnline Volltext: dx.doi.org/ (Open Access)
-
A vaccine targeting mutant IDH1 in newly diagnosed gliomaIn: Nature Jg. 592 (2021) S. 463 - 468ISSN: 0028-0836; 1476-4687Online Volltext: dx.doi.org/ (Open Access)
-
Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative studyIn: Supportive Care in Cancer Jg. 29 (2021) Nr. 9, S. 5127 - 5137ISSN: 1433-7339; 0941-4355Online Volltext: dx.doi.org/ (Open Access)
-
Electrolyte and renal disorders in patients with newly diagnosed glioblastomaIn: Future Oncology Jg. 17 (2021) Nr. 34, S. 4711 - 4719ISSN: 1479-6694; 1744-8301Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access)
-
HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain MetastasesIn: World Neurosurgery Jg. 152 (2021) S. e332 - e343ISSN: 1878-8769; 1878-8750Online Volltext: dx.doi.org/
-
PARPACT – Paramedic Palliative Care Test : Validierung eines Tests für palliatives Wissen und Selbstwirksamkeitserwartung bei Mitarbeiter*innen im RettungswesenIn: Der Schmerz (2021) in pressISSN: 1432-2129; 0932-433XOnline Volltext: dx.doi.org/ (Open Access)
-
Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patientsIn: BMC Palliative Care Jg. 19 (2020) Nr. 1, S. 43ISSN: 1472-684XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer centerIn: Journal of Cancer Research and Clinical Oncology (2020)ISSN: 1432-1335; 0171-5216Online Volltext: dx.doi.org/ (Open Access)
-
Integration of palliative care into the comprehensive cancer center of Germany - Consultation hours and fellowship rotations of the specialized palliative careIn: TumorDiagnostik & Therapie Jg. 40 (2019) Nr. 5, S. 293 - 299ISSN: 1439-1279; 0722-219XOnline Volltext: dx.doi.org/
-
Knowledge and Self-Efficacy Assessment of Residents and Fellows Following Palliative Care Unit Rotation : A Pilot StudyIn: American Journal of Hospice & Palliative Medicine Jg. 36 (2019) Nr. 6, S. 492 - 499ISSN: 1938-2715; 1049-9091; 0749-1565Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicityIn: Journal of the Peripheral Nervous System Jg. 24 (2019) Nr. 1, S. 111 - 119ISSN: 1529-8027; 1085-9489Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell LymphomasIn: Oncology Research and Treatment Jg. 42 (2019) Nr. 11,ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/
-
11C-MET PET/MRI for detection of recurrent gliomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 593 - 601ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/
-
Integration von Palliativmedizin in onkologische Spitzenzentren Deutschlands – ambulante Sprechstunden und Rotationsprogramme der spezialisierten PalliativmedizinIn: Deutsche Medizinische Wochenschrift - DMW Jg. 143 (2018) Nr. 17, S. e139 - e145ISSN: 1439-4413; 0012-0472; 1437-5982Online Volltext: dx.doi.org/
-
MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyIn: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463ISSN: 1938-0690; 1525-7304Online Volltext: dx.doi.org/
-
Patient-Reported-Outcome-Messung (PROM) psychosozialer Belastung und Symptome für ambulante Patienten unter kurativer oder palliativer Tumortherapie : eine retrospektive Analyse eines Comprehensive Cancer CenterIn: Der Onkologe Jg. 24 (2018) Nr. 1, S. 69 - 75ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer centerIn: Supportive Care in Cancer Jg. 26 (2018) Nr. 10, S. 3641 - 3647ISSN: 1433-7339; 0941-4355Online Volltext: dx.doi.org/
-
PriCoTTF : A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastomaIn: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. 73ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ (Open Access)
-
SOP – FatigueIn: Der Onkologe Jg. 24 (2018) Nr. Suppl. 1, S. 41 - 47ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
SOP – Schmerztherapie bei PalliativpatientenIn: Der Onkologe Jg. 24 (2018) Nr. Suppl. 1, S. 7 - 17ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
SOP – Subkutane Medikamentengabe und Infusionen in der erwachsenen PalliativmedizinIn: Der Onkologe Jg. 24 (2018) Nr. Suppl. 1, S. 60 - 67ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung CancerIn: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/ (Open Access)
-
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI : a feasibility studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 8, S. 1285 - 1295ISSN: 1619-7089; 1619-7070; 1432-105X; 0340-6997Online Volltext: dx.doi.org/
-
SOP – FatigueIn: Der Onkologe Jg. 23 (2017) Nr. 6, S. 462 - 468ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
SOP – Schmerztherapie bei PalliativpatientenIn: Der Onkologe Jg. 23 (2017) Nr. 7, S. 555 - 565ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
SOP – Subkutane Medikamentengabe und Infusionen in der erwachsenen PalliativmedizinIn: Der Onkologe Jg. 23 (2017) Nr. 8, S. 657 - 664ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/
-
Integration der Palliativmedizin in die von der Deutschen Krebshilfe e. V. geförderten onkologischen SpitzenzentrenIn: Deutsche Medizinische Wochenschrift: DMW Jg. 141 (2016) Nr. 2, S. e16 - e23ISSN: 1439-4413; 0012-0472Online Volltext: dx.doi.org/
-
Simultaneous 11C-methionine position emission tomography/magnetic resonance imaging of suspected primary brain tumorsIn: PLoS ONE Jg. 11 (2016) Nr. 12, S. e0167596ISSN: 1932-6203Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Outcomes of Primary and Secondary Transformed B-Cell LymphomasIn: Blood Jg. 126 (2015) Nr. 23,ISSN: 1528-0020; 0006-4971
-
Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy : A Case Report and Review of the LiteratureIn: AJP Reports Jg. 4 (2014) Nr. 1, S. 017 - 022ISSN: 2157-6998Online Volltext: dx.doi.org/ (Open Access)
-
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: : Secondary analysis of data from the CI-PeriNomS studyIn: Journal of the Peripheral Nervous System Jg. 19 (2014) Nr. 2, S. 127 - 135ISSN: 1529-8027; 1085-9489Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Formation of multiple pneumatoceles during anti-angiogenic treatment for metastatic colorectal cancerIn: Oncology Research and Treatment / Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg Jg. 37 (2014) Nr. Suppl. 5, S. 84 - 85ISSN: 2296-5262
-
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity : two sides of the same coinIn: Annals of Oncology Jg. 25 (2014) Nr. 1, S. 257 - 264ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/
-
Brief S2k guidelines : merkel cell carcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. Suppl. 3, S. 29 - 36ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481Online Volltext: dx.doi.org/
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer Jg. 49 (2013) Nr. 15, S. 3076 - 3082ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88ISSN: 1573-7217; 0167-6806Online Volltext: dx.doi.org/
-
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)In: European Journal of Cancer Jg. 49 (2013) Nr. 13, S. 2910 - 2918ISSN: 0959-8049; 1879-0852Online Volltext: dx.doi.org/
-
The chemotherapy-induced peripheral neuropathy outcome measures standardization study : From consensus to the first validity and reliability findingsIn: Annals of Oncology Jg. 24 (2013) Nr. 2, S. 454 - 462ISSN: 1569-8041Online Volltext: dx.doi.org/
-
Visual field defect related to temozolomideIn: Neuro-Oncology Jg. 15 (2013) Nr. Suppl. 3, S. 116ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/
-
An investigator-initiated monocentric phase I dose escalation trial of temsirolimus and irinotecan (TEMIR) in patients with relapsing glioblastoma multiforme (reGBM)In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. 2086ISSN: 0732-183X; 1527-7755
-
Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) - a single center experienceIn: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438ISSN: 0923-7534; 1569-8041
-
Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octrotateIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 39 (2012) Nr. Suppl. 2, S. 233ISSN: 1619-7070; 1619-7089
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204ISSN: 0378-584X; 1423-0240
-
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatmentIn: International Journal of Clinical Pharmacology and Therapeutics Jg. 49 (2011) Nr. 1, S. 96 - 98ISSN: 0946-1965Online Volltext: dx.doi.org/
-
Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide : case report and literature reviewIn: European Journal of Medical Research Jg. 16 (2011) Nr. 9, S. 415 - 419ISSN: 2047-783X; 0949-2321Online Volltext: dx.doi.org/ (Open Access)
-
Multivisceral systemic metastases from an intracranial anaplastic meningioma : A case report and review of literatureIn: Clinical Neurology and Neurosurgery Jg. 113 (2011) Nr. 7, S. 592 - 595ISSN: 0303-8467; 1872-6968Online Volltext: dx.doi.org/
-
Register trial of sorafenib (S) for patients (pts) with metastatic uveal melanoma (metUvMel)In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 4, S. S30ISSN: 0959-8049Online Volltext: dx.doi.org/
-
Treatable Bortezomib-related peripheral neuropathy in multiple myelomaIn: Journal of Peripheral Nervous Systems Jg. 16 (2011) Nr. Suppl. 3, S. 68ISSN: 1085-9489; 1529-8027
-
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphomaIn: Journal of Cancer Research and Clinical Oncology Jg. 135 (2009) Nr. 3, S. 459 - 466ISSN: 1432-1335; 0171-5216Online Volltext: dx.doi.org/
-
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myelomaIn: European Journal of Haematology Jg. 74 (2005) Nr. 1, S. 40 - 46ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/
-
Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world settingIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 812ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access)
-
Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical IrradiationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 183ISSN: 1439-099X; 0179-7158
-
Influence of external and self-assessment in symptom burden of cancer patients in a palliative care outpatient clinic of a Comprehensive Cancer Center
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 92ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 58ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 210ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Barriers and motivation of physical activitiy (PA) in patients with cancer related fatigue (CRF)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 165ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomasIn: Neuro-Oncology Jg. 20 (2018) Nr. suppl_3, S. iii226 - iii227ISSN: 1523-5866Online Volltext: dx.doi.org/ (Open Access)
-
A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas : A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16)In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 2001ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,In: Neuro-Oncology Jg. 20 (2018) Nr. suppl_6, S. vi22 - vi23ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ (Open Access) -
ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,In: Neuro-Oncology Jg. 20 (2018) Nr. suppl_6, S. vi8 - vi9ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ (Open Access) -
PriCoTTF : a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastomaIn: Neuro-Oncology Jg. 20 (2018) Nr. suppl_3, S. iii243 - iii243ISSN: 1523-5866Online Volltext: dx.doi.org/ (Open Access)
-
Palliative Care at Comprehensive Cancer Center : A comparative look at integration in Germany
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 129ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19ISSN: 2296-5262Online Volltext: dx.doi.org/ (Open Access)
-
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Physician-assessed and petient-reported outcome measuresin chemotherapy-induced sensory peripheral neurotoxicity : two sides of the same coin
Meeting of the Peripheral Nerve Society, June 29–July 3, 2013, Saint–Malo, France,In: Journal of the Peripheral Nervous System Jg. 18 (2013) Nr. S2, S. 3 - 4ISSN: 1529-8027; 1085-9489Online Volltext: dx.doi.org/ -
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Oncology Research and Treatment Jg. 36 (2013) Nr. Suppl. 7, S. 157ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Provider perceptions of clinical neuropathy examination usefulness
Meeting of the Peripheral Nerve Society, June 29–July 3, 2013, Saint–Malo, France,In: Journal of the Peripheral Nervous System Jg. 18 (2013) Nr. 2, S. 42 - 43ISSN: 1529-8027; 1085-9489Online Volltext: dx.doi.org/